US Patent Issued to Viridian Therapeutics on Sept. 2 for "Compositions and methods for treatment of thyroid eye disease" (Massachusetts, Puerto Rico Inventors)

ALEXANDRIA, Va., Sept. 3 -- United States Patent no. 12,404,335, issued on Sept. 2, was assigned to Viridian Therapeutics Inc. (Waltham, Mass.).

"Compositions and methods for treatment of thyroid eye disease" was invented by Vahe Bedian (Waltham, Mass.), Peter Harwin (Dorado, Puerto Rico), Tomas Kiselak (Dorado, Puerto Rico), Angela She (Waltham, Mass.), Jonathan Violin (Waltham, Mass.) and Yang Zhao (Waltham, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Antibodies and compositions against Insulin-Like Growth Factor-1 Receptor (IGF-1R) and uses thereof for treating thyroid eye disease (TED) are provided herein. Anti-IGF-1R antibodies and compositions described herein can be used in methods of treatin...